{"id":52281,"date":"2025-12-30T21:28:38","date_gmt":"2025-12-30T13:28:38","guid":{"rendered":"https:\/\/flcube.com\/?p=52281"},"modified":"2025-12-30T21:28:40","modified_gmt":"2025-12-30T13:28:40","slug":"broncus-medical-acquires-valgen-stake-from-venus-for-15-million","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=52281","title":{"rendered":"Broncus Medical Acquires Valgen Stake from Venus for $15 Million"},"content":{"rendered":"\n<p><strong>Broncus Medical<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/2216:HKG\">HKG: 2216<\/a>) announced that its wholly\u2011owned subsidiary, <strong>Broncus China Holding Corporation<\/strong>, has agreed to acquire <strong>157,800 Series B Preferred Shares<\/strong> of <strong>Valgen Holding Corporation<\/strong> from <strong>Venus Medtech (Hangzhou) Inc.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/2500:HKG\">HKG: 2500<\/a>) for <strong>US$15\u202fmillion<\/strong> cash, representing <strong>1.05%<\/strong> of Valgen\u2019s issued share capital. Upon completion, Venus Medtech will exit its position in Valgen Holding.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-overview\">Transaction Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Acquirer<\/strong><\/td><td>Broncus Medical (2216.HK) via Broncus China Holding<\/td><\/tr><tr><td><strong>Seller<\/strong><\/td><td>Venus Medtech (Hangzhou) Inc. (2500.HK)<\/td><\/tr><tr><td><strong>Target<\/strong><\/td><td>Valgen Holding Corporation<\/td><\/tr><tr><td><strong>Asset<\/strong><\/td><td>157,800 Series B Preferred Shares (1.05% stake)<\/td><\/tr><tr><td><strong>Consideration<\/strong><\/td><td>US$15\u202fmillion cash<\/td><\/tr><tr><td><strong>Transaction Date<\/strong><\/td><td>29\u202fDec\u202f2025<\/td><\/tr><tr><td><strong>Post\u2011Transaction<\/strong><\/td><td>Venus Medtech holds 0% in Valgen<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-company-profiles\">Company Profiles<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Company<\/th><th>Focus Area<\/th><th>Core Competency<\/th><th>Market Position<\/th><\/tr><\/thead><tbody><tr><td><strong>Broncus Medical<\/strong><\/td><td>Interventional pulmonology<\/td><td>Medical devices &amp; consumables for lung disease<\/td><td>Leading China player<\/td><\/tr><tr><td><strong>Valgen Holding<\/strong><\/td><td>Structural heart disease<\/td><td>Interventional technologies for cardiac conditions<\/td><td>R&amp;D\u2011stage innovator<\/td><\/tr><tr><td><strong>Venus Medtech<\/strong><\/td><td>Cardiovascular devices<\/td><td>Investment &amp; portfolio management<\/td><td>Exiting Valgen position<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-synergy-analysis\">Strategic Synergy Analysis<\/h2>\n\n\n\n<p><strong>Rationale for Acquisition<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Cardiopulmonary Integration<\/strong>: Structural heart disease and pulmonary diseases share <strong>clinical correlations<\/strong>; combined expertise enables <strong>integrated diagnosis and treatment<\/strong><\/li>\n\n\n\n<li><strong>Technology Transfer<\/strong>: Valgen\u2019s interventional technologies can be <strong>adapted for pulmonary applications<\/strong>, accelerating Broncus\u2019s R&amp;D pipeline<\/li>\n\n\n\n<li><strong>Cross\u2011Specialty Platform<\/strong>: Both fields utilize <strong>catheter\u2011based interventions<\/strong>; knowledge sharing reduces development risk and expands addressable market<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-opportunity\">Market Opportunity<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Segment<\/th><th>China Market Size (2025)<\/th><th>Growth Driver<\/th><th>Broncus\u2011Valgen Synergy<\/th><\/tr><\/thead><tbody><tr><td><strong>Interventional Pulmonology<\/strong><\/td><td>\u00a58.5\u202fbillion (US$1.2\u202fB)<\/td><td>COPD, lung cancer screening<\/td><td>Apply cardiac navigation to lung procedures<\/td><\/tr><tr><td><strong>Structural Heart Disease<\/strong><\/td><td>\u00a512.0\u202fbillion (US$1.7\u202fB)<\/td><td>Aging population, TAVR growth<\/td><td>Leverage lung imaging for cardiac interventions<\/td><\/tr><tr><td><strong>Combined Cardiopulmonary<\/strong><\/td><td><strong>\u00a520.5\u202fbillion<\/strong> (US$2.9\u202fB)<\/td><td>Integrated care models<\/td><td><strong>Cross\u2011pollination of interventional tech<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financial-implications\">Financial Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Investment Size<\/strong>: US$15\u202fmillion represents <strong>2.1%<\/strong> of Broncus Medical\u2019s cash position (HK$5.6\u202fbillion as of H1\u202f2025)<\/li>\n\n\n\n<li><strong>Valuation<\/strong>: Implies <strong>US$1.43\u202fbillion<\/strong> post\u2011money valuation for Valgen Holding<\/li>\n\n\n\n<li><strong>Accounting Treatment<\/strong>: Minority stake to be recorded as <strong>long\u2011term equity investment<\/strong><\/li>\n\n\n\n<li><strong>Earnings Impact<\/strong>: No immediate P&amp;L impact; potential for <strong>R&amp;D cost synergies<\/strong> of <strong>\u00a530\u201150\u202fmillion<\/strong> annually by 2027<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding Broncus Medical\u2019s strategic synergies, Valgen Holding\u2019s technology applications, and potential cost savings. Actual results may differ due to integration challenges, clinical development risks, and competitive dynamics in interventional cardiopulmonary markets.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/2025122901562_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2025122901562_c.\"><\/object><a id=\"wp-block-file--media-070a5df5-2ffd-44e4-a784-cbfcf8bd4c1e\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/2025122901562_c.pdf\">2025122901562_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/2025122901562_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-070a5df5-2ffd-44e4-a784-cbfcf8bd4c1e\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Broncus Medical (HKG: 2216) announced that its wholly\u2011owned subsidiary, Broncus China Holding Corporation, has agreed&#8230;<\/p>\n","protected":false},"author":1,"featured_media":52283,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[1287,1288,1093,258],"class_list":["post-52281","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-broncus-medical","tag-hkg-2216","tag-hkg-2500","tag-venus-medtech"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Broncus Medical Acquires Valgen Stake from Venus for $15 Million - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Broncus Medical (HKG: 2216) announced that its wholly\u2011owned subsidiary, Broncus China Holding Corporation, has agreed to acquire 157,800 Series B Preferred Shares of Valgen Holding Corporation from Venus Medtech (Hangzhou) Inc. (HKG: 2500) for US$15\u202fmillion cash, representing 1.05% of Valgen\u2019s issued share capital. Upon completion, Venus Medtech will exit its position in Valgen Holding.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=52281\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Broncus Medical Acquires Valgen Stake from Venus for $15 Million\" \/>\n<meta property=\"og:description\" content=\"Broncus Medical (HKG: 2216) announced that its wholly\u2011owned subsidiary, Broncus China Holding Corporation, has agreed to acquire 157,800 Series B Preferred Shares of Valgen Holding Corporation from Venus Medtech (Hangzhou) Inc. (HKG: 2500) for US$15\u202fmillion cash, representing 1.05% of Valgen\u2019s issued share capital. Upon completion, Venus Medtech will exit its position in Valgen Holding.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=52281\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-30T13:28:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-30T13:28:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3005-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52281#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52281\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Broncus Medical Acquires Valgen Stake from Venus for $15 Million\",\"datePublished\":\"2025-12-30T13:28:38+00:00\",\"dateModified\":\"2025-12-30T13:28:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52281\"},\"wordCount\":376,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52281#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/3005-1.webp\",\"keywords\":[\"Broncus Medical\",\"HKG: 2216\",\"HKG: 2500\",\"Venus Medtech\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=52281#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52281\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=52281\",\"name\":\"Broncus Medical Acquires Valgen Stake from Venus for $15 Million - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52281#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52281#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/3005-1.webp\",\"datePublished\":\"2025-12-30T13:28:38+00:00\",\"dateModified\":\"2025-12-30T13:28:40+00:00\",\"description\":\"Broncus Medical (HKG: 2216) announced that its wholly\u2011owned subsidiary, Broncus China Holding Corporation, has agreed to acquire 157,800 Series B Preferred Shares of Valgen Holding Corporation from Venus Medtech (Hangzhou) Inc. (HKG: 2500) for US$15\u202fmillion cash, representing 1.05% of Valgen\u2019s issued share capital. Upon completion, Venus Medtech will exit its position in Valgen Holding.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52281#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=52281\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52281#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/3005-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/3005-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Broncus Medical Acquires Valgen Stake from Venus for $15 Million\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52281#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Broncus Medical Acquires Valgen Stake from Venus for $15 Million\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Broncus Medical Acquires Valgen Stake from Venus for $15 Million - Insight, China&#039;s Pharmaceutical Industry","description":"Broncus Medical (HKG: 2216) announced that its wholly\u2011owned subsidiary, Broncus China Holding Corporation, has agreed to acquire 157,800 Series B Preferred Shares of Valgen Holding Corporation from Venus Medtech (Hangzhou) Inc. (HKG: 2500) for US$15\u202fmillion cash, representing 1.05% of Valgen\u2019s issued share capital. Upon completion, Venus Medtech will exit its position in Valgen Holding.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=52281","og_locale":"en_US","og_type":"article","og_title":"Broncus Medical Acquires Valgen Stake from Venus for $15 Million","og_description":"Broncus Medical (HKG: 2216) announced that its wholly\u2011owned subsidiary, Broncus China Holding Corporation, has agreed to acquire 157,800 Series B Preferred Shares of Valgen Holding Corporation from Venus Medtech (Hangzhou) Inc. (HKG: 2500) for US$15\u202fmillion cash, representing 1.05% of Valgen\u2019s issued share capital. Upon completion, Venus Medtech will exit its position in Valgen Holding.","og_url":"https:\/\/flcube.com\/?p=52281","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-12-30T13:28:38+00:00","article_modified_time":"2025-12-30T13:28:40+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3005-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=52281#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=52281"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Broncus Medical Acquires Valgen Stake from Venus for $15 Million","datePublished":"2025-12-30T13:28:38+00:00","dateModified":"2025-12-30T13:28:40+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=52281"},"wordCount":376,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=52281#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3005-1.webp","keywords":["Broncus Medical","HKG: 2216","HKG: 2500","Venus Medtech"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=52281#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=52281","url":"https:\/\/flcube.com\/?p=52281","name":"Broncus Medical Acquires Valgen Stake from Venus for $15 Million - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=52281#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=52281#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3005-1.webp","datePublished":"2025-12-30T13:28:38+00:00","dateModified":"2025-12-30T13:28:40+00:00","description":"Broncus Medical (HKG: 2216) announced that its wholly\u2011owned subsidiary, Broncus China Holding Corporation, has agreed to acquire 157,800 Series B Preferred Shares of Valgen Holding Corporation from Venus Medtech (Hangzhou) Inc. (HKG: 2500) for US$15\u202fmillion cash, representing 1.05% of Valgen\u2019s issued share capital. Upon completion, Venus Medtech will exit its position in Valgen Holding.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=52281#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=52281"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=52281#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3005-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3005-1.webp","width":1080,"height":608,"caption":"Broncus Medical Acquires Valgen Stake from Venus for $15 Million"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=52281#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Broncus Medical Acquires Valgen Stake from Venus for $15 Million"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3005-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=52281"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52281\/revisions"}],"predecessor-version":[{"id":52284,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52281\/revisions\/52284"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/52283"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=52281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=52281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=52281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}